133 related articles for article (PubMed ID: 1833326)
1. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia.
Clowes AW; Clowes MM; Vergel SC; Müller RK; Powell JS; Hefti F; Baumgartner HR
Hypertension; 1991 Oct; 18(4 Suppl):II65-9. PubMed ID: 1833326
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors.
Powell JS; Muller RK; Baumgartner HR
J Am Coll Cardiol; 1991 May; 17(6 Suppl B):137B-142B. PubMed ID: 1826694
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.
Hanson SR; Powell JS; Dodson T; Lumsden A; Kelly AB; Anderson JS; Clowes AW; Harker LA
Hypertension; 1991 Oct; 18(4 Suppl):II70-6. PubMed ID: 1833327
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitor cilazapril suppresses expression of basic fibroblast growth factor messenger ribonucleic acid and protein in endothelial and intimal smooth muscle cells in a vascular injury model of spontaneous hypertensive rats.
Iwata A; Masago A; Yamada K
Neurol Med Chir (Tokyo); 1998 May; 38(5):257-64; discussion 264-5. PubMed ID: 9640960
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries.
Fingerle J; Müller RM; Kuhn H; Pech M; Baumgartner HR
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1945-50. PubMed ID: 7583575
[TBL] [Abstract][Full Text] [Related]
6. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells.
Powell JS; Rouge M; Müller RK; Baumgartner HR
Basic Res Cardiol; 1991; 86 Suppl 1():65-74. PubMed ID: 1827985
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin II in injury-induced neointima formation in rats.
Osterrieder W; Müller RK; Powell JS; Clozel JP; Hefti F; Baumgartner HR
Hypertension; 1991 Oct; 18(4 Suppl):II60-4. PubMed ID: 1833325
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.
Powell JS; Clozel JP; Müller RK; Kuhn H; Hefti F; Hosang M; Baumgartner HR
Science; 1989 Jul; 245(4914):186-8. PubMed ID: 2526370
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of intimal hyperplasia after arterial injury by heparins and heparinoid.
Dryjski M; Mikat E; Bjornsson TD
J Vasc Surg; 1988 Nov; 8(5):623-33. PubMed ID: 2460647
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs.
Clozel JP; Hess P; Michael C; Schietinger K; Baumgartner HR
Hypertension; 1991 Oct; 18(4 Suppl):II55-9. PubMed ID: 1833324
[TBL] [Abstract][Full Text] [Related]
11. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.
Powell JS; Müller RK; Rouge M; Kuhn H; Hefti F; Baumgartner HR
J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S42-9. PubMed ID: 1705627
[TBL] [Abstract][Full Text] [Related]
12. Prevention of neointima formation by mibefradil after vascular injury in rats: comparison with ACE inhibition.
Schmitt R; Clozel JP; Iberg N; Bühler FR
Cardiovasc Drugs Ther; 1996 May; 10(2):101-5. PubMed ID: 8842500
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of cilazapril on the cerebral circulation.
Véniant M; Clozel JP; Kuhn H; Clozel M
J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S94-9. PubMed ID: 1382172
[TBL] [Abstract][Full Text] [Related]
14. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition.
Clozel M; Kuhn H; Hefti F; Baumgartner HR
Hypertension; 1991 Aug; 18(2):132-41. PubMed ID: 1653185
[TBL] [Abstract][Full Text] [Related]
16. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries.
Lam JY; Lacoste L; Bourassa MG
Circulation; 1992 Apr; 85(4):1542-7. PubMed ID: 1532544
[TBL] [Abstract][Full Text] [Related]
17. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.
Edelman ER; Adams DH; Karnovsky MJ
Proc Natl Acad Sci U S A; 1990 May; 87(10):3773-7. PubMed ID: 2339120
[TBL] [Abstract][Full Text] [Related]
18. Cilazapril inhibits wall thickening of vein bypass graft in the rat.
Roux SP; Clozel JP; Kuhn H
Hypertension; 1991 Oct; 18(4 Suppl):II43-6. PubMed ID: 1833323
[TBL] [Abstract][Full Text] [Related]
19. Failure of heparin to inhibit the expression of the thrombin receptor following endothelial injury of the rabbit carotid artery.
Guitteny AF; Herbert JM
Eur J Pharmacol; 1997 May; 327(2-3):157-62. PubMed ID: 9200554
[TBL] [Abstract][Full Text] [Related]
20. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.
Kawamura M; Terashita Z; Okuda H; Imura Y; Shino A; Nakao M; Nishikawa K
J Pharmacol Exp Ther; 1993 Sep; 266(3):1664-9. PubMed ID: 8371164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
